Skip to Main Content
Ko Sakamoto
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 3 Clinical Study to Evaluate the Long-Term Safety and Tolerability of 20% IGSC for Japanese Patients with PID

Hirokazu Kanekane, Satoshi Okada, Hidenori Ohnishi, Kohsuke Imai, Taizo Wada, Ryuta Nishikomori, Atsushi Kuga, Ko Sakamoto, Sharon Russo-Schwarzbaum, Barbara McCoy, Zhaoyang Li, Leman Yel
Journal: Journal of Human Immunity
Series: JSIAD Meeting Abstracts 2026
J Hum Immun (2026) 2 (JSIAD2026): eJSIAD2026abstract.37.
https://doi.org/10.70962/JSIAD2026abstract.37
Published: 04 June 2026
View article titled, A Phase 3 Clinical Study to Evaluate the Long-Term Safety and Tolerability of 20% IGSC for Japanese Patients with PID
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Please sign in to your personal account to gift article access.

Register

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses.

You have reached the limit of 10 links within a 30 day period.

Sharing Unavailable

Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.